Lecture 7.0 Pancytopenia 2024 Flashcards
Name 2 approaches to pancytopenia
- Pancytopenia with hypercellular bone marrow
- Pancytopenia with hypocellular bone marrow
-Can be congenital, can be acquired
What are the acquired forms of hypocellular pancytopenia?
- Primary idiopathic aplastia anaemia
- Secondary aplastic anaemia
- Miscellaneous disorders (Myelofibrosis, extensive
granulomatous inflammation, marrow necrosis)
What are the congenital forms of hypocellular pancytopenia?
- Fanconi anaemia
- Dyskeratosis congenita
- Schwachman-Diamond syndrome
Primary idiopathic aplastic anaemia
Characterized by hypocellular marrow with a peripheral pancytopenia without a bone marrow infiltrate or increase in marrow fibrosis
- Presents with signs and symptoms of bone
marrow failure (i.e bleeding, symptoms of anaemia, infection) - Rare disease, with a relatively higher incidence in Asia
Name the 2 pathophysiologies seen with Primary AA, and their treatment
- Pathophysiology- Immune defect
*Oligoclonal
expansion of
cytotoxic T-cells
targeting
haemopoietic stem
cells
Treatment:
- Immunosuppressive
therapy
*Antithymocyte
globulin (ATG) +
Cyclosporin (CSA
- Pathophysiology- Decreased number and quality of haemopoietic stem cells
Treatment: Allogeneic
Haemopoietic stem
cell transplant (HSCT
Discuss the Biphasic age distribution of Primary idiopathic aplastic anaemia
1 peak between 10-25 years, and another >60 years
*M:F ratio ~1:1
Discuss the Severity grading of Primary AA
Severity grading of Primary AA:
- Severe:
–Bone marrow cellularity <25% + 2/3 of the following:
*Neuts: <0.5x10^9/l
*Plts: <20x10^9/l and/or
*Reticulocytes <20x10^9/l - Very severe:
–As above, but neuts <0.2x10^9/l - Non-severe:
–Not severe or very severe
A polyclonal IgG antibody preparation produced
by immunizing horses/rabbits with human
Thymocytes.
ATG
It causes profound T-cell depletion, and is a
powerful immunosuppressive
ATG
What’s are the possible side effects of ATG?
- Allergy and
- serum sickness (happens when your body reacts to certain medications, antiserum (used to treat infections or venom), or other proteins from non-human sources)
(7-14 days after therapy commencement).
*It is therefore always given with a corticosteroid and an antihistamine
Patients referred to as transfussion independent
Those responding to ATG (which is normally 2/3rd of patients)
*Up to ~1/3rd of these will relapse.
What are the problems that result with with HSCT among siblings (Hematopoietic Stem Cell Transplantation)?
- Potentially serious complications, particularly
graft vs host disease.
– At risk of secondary malignancies in later life.
– Many patients don’t have a matched sibling
What’s the response rate of the HSCT (Hematopoietic Stem Cell Transplantation) with best
results in young sibling matched transplants patients
90 %
Problems with HSCT
- Potentially serious complications, particularly
graft vs host disease.
– At risk of secondary malignancies in later life.
– Many patients don’t have a matched sibling
The 3 causes of 2ndary aplastic anemia/ aplasia
- Drugs
- Toxins
- Irradiation
- Infection (viral (EBV, CMV, Hepatitis B and C, HIV,
Parvovirus), Mycobacteria - Auto-immune pathology (such as SLE)
- Miscellaneous (Prolonged starvation (including
Anorexia nervosa), pregnancy, thymoma) - Clonal myeloid disorders (Including hypoplastic
MDS, hypoplastic AML and Paroxysmal nocturnal
haemoglobinuria (PNH))
hereditary pattern of Fanconi anaemia
Autosomal recessive disorder
What causes Fanconi anamia?
Caused by a mutation in one of the FANC genes:
(FANCA , FANCB , FANCC , FANCD1 , FANCD2 , FANCE , FANCF ,FANCG , FANCI , FANCJ , FANCL , FANCM or FANCN), whichencode proteins involved with DNA repair.
Impact of Fanconi anaemia on bone marrow. What is Fanconi anaemia associated with in the bone marrow?
Associated with bone marrow failure and an increased predisposition to malignancy (especially AML)- Acute Myeloid Leukemia
What are the clinical features of fanconi anaemia?
- Pancytopenia develops insidiously and presents in most cases between the ages of 5 and 10 years.
- One or more associated somatic abnormalities in 2/3rds of cases:
–café - au - lait spots
–skeletal abnormalities (short stature, absent/fingerised thumbs, radial hypoplasia)
–micro-opthalmia
–genitourinary, gastrointestinal, cardiac and/or neurological anomalies.
Diagnoses of Fanconi anaemia
– Chromosome breakage studies
– Genetic testing for FANC
mutations
Treatment of Fanconi anaemia
– Supportive measures
– Androgens (oxymetholone) or corticosteroids (prednisone) therapy to boost haemopoeitic function.
– HSCT with a reduced intensity conditioning regimen
- Prognosis: Average life expectancy is ~24 yrs.
Features of hypercellular pancytopenia
- Bone marrow infiltration
- Ineffective haemopoiesis
- Hypersplenism (condition where the spleen becomes overactive and removes blood cells from circulation faster than normal)
- Other
–Haemophagocytic lymphohistiocytosis (HLH)
–Multifactorial effects
Two forms of bone marrow infiltration
- Benign
– Granulomata
(Mycobacterial infection,
fungal infection,
Sarcoidosis etc) - Malignant
– Acute leukaemia (AML
(particularly APL) or ALL)
– Lymphoma (Hodgkin or
non-Hodgkin)
– Hairy cell leukaemia
– Non-haemopoietic
tumours (small round blue
cell tumours of childhood,
Carcinomas etc)